Newsletter registration

By using our website, you are agreeing to cookies being stored and Google Analytics being used on your device in order to offer the best possible service. You can find more information on thishere.
Austria.
Dynamic Business Location.

Swallowable cancer immune therapy being developed

Apeiron Biologics CEO Hans Loibner said: "Our concept is that we would like to develop small molecule (synthetically produced) substances which provide the immune system with specific properties.” Apeiron and Evotec established a screening system to search through a substance library containing about 100,000 substances to find an enhancing effect on immune cells. Several drug candidates were discovered within the context of the project APN411.

In contrast to monoclonal antibodies, the new drug candidates showed in laboratory tests that they could trigger several effects in the immune cells. These produce more of the anti-tumor messenger substances interleukin-2, interferon gamma and tumor necrosis factor alpha. The T-cells showed enhanced activity.  

It is also decisive for the project that the substances are small and can be very effectively produced on an industrial scale.  

Apeiron, founded by Josef Penninger, Head of the Institute for Molecular Biotechnology in Vienna (IMBA), is already involved in early clinical tests in the USA with APN401, another cancer checkpoint project. A medicine developed by Apeiron to treat brain tumors in children is awaiting approval by the European Medicines Agency (EMA). 

Share on Facebook Share on Facebook Share on Twitter Share on Twitter Share on Linkedin Share on Linkedin

Testimonials

Events

Meet us at events, seminars and trade shows - worldwide.

  • 17. Mittelstandstag FrankfurtRheinMain

    07.11.2019, Frankfurt on the Main, Germany

  • MEDICA 2019

    18.11.- 21.11. 2019, Dusseldorf, Germany, Germany

Austria Map

Find the perfect location for your company

Austria offers the comfort and infrastracture of a western industrial nation. The high quality of life is an advantage when it comes to attracting top executives from around the world to our headquarters here.

Coca-Cola Austria

Logo
More testimonials

news from the business location Austria

Siemens: New robot welding plant in Graz

Siemens Mobility has put a new robot-controlled frame welding facility into operation in Graz.

Coming back for seconds: Why big brands expand their (R&D) presence in Austria

The high-tech multinational Infineon is investing more than EUR 1.6 billion to expand its main facility in Austria. The pharmaceutical company Octapharma is massively expanding its Vienna-based operations at a cost of EUR 142 million. Headlines like these have recently caused people to sit up and take notice. But the question is: why is Austria as a research location so popular with international firms which are already established here?

More news All blog posts